Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Quon

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Plos One|February 2, 2023
In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiationMichelle Jun, Harlan Pinto, Quynh-Thu Le, et al.
EJNMMI Physics|March 10, 2016
Correlation between arterial spin labeling MRI and dynamic FDG on PET-MR in Alzheimer's disease and non-Alzhiemer's disease patientsDavid Douglas, Maged Goubran, Eugene Wilson, et al.
Technology in Cancer Research & Treatment|January 24, 2007
Impact of integrated PET/CT on variability of target volume delineation in rectal cancerDeep A Patel, Stephanie T Chang, Karyn A Goodman, et al.
Molecular Imaging and Biology|October 13, 2005
Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patientsBarbara J Fueger, Wolfgang A Weber, Andrew Quon, et al.
Radiation Oncology (London, England)|January 21, 2012
Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's diseaseDiane Tseng, Leelanand P Rachakonda, Zheng Su, et al.
Practical Radiation Oncology|March 10, 2017
Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PETDiego A S Toesca, Erqi L Pollom, Peter D Poullos, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2010
Postradiation metabolic tumor volume predicts outcome in head-and-neck cancerJames D Murphy, Trang H La, Karen Chu, et al.
Clinical Lung Cancer|June 28, 2011
Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancerPercy Lee, Jose G Bazan, Philip W Lavori, et al.
Cancer|January 2, 2009
Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreasDaniel T Chang, Devin Schellenberg, John Shen, et al.
The Lancet. Oncology|February 25, 2014
Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre studyChristopher Klenk, Rakhee Gawande, Lebriz Uslu, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Plos One|February 2, 2023
In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiationMichelle Jun, Harlan Pinto, Quynh-Thu Le, et al.
EJNMMI Physics|March 10, 2016
Correlation between arterial spin labeling MRI and dynamic FDG on PET-MR in Alzheimer's disease and non-Alzhiemer's disease patientsDavid Douglas, Maged Goubran, Eugene Wilson, et al.
Technology in Cancer Research & Treatment|January 24, 2007
Impact of integrated PET/CT on variability of target volume delineation in rectal cancerDeep A Patel, Stephanie T Chang, Karyn A Goodman, et al.
Molecular Imaging and Biology|October 13, 2005
Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patientsBarbara J Fueger, Wolfgang A Weber, Andrew Quon, et al.
Radiation Oncology (London, England)|January 21, 2012
Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's diseaseDiane Tseng, Leelanand P Rachakonda, Zheng Su, et al.
Practical Radiation Oncology|March 10, 2017
Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PETDiego A S Toesca, Erqi L Pollom, Peter D Poullos, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2010
Postradiation metabolic tumor volume predicts outcome in head-and-neck cancerJames D Murphy, Trang H La, Karen Chu, et al.
Clinical Lung Cancer|June 28, 2011
Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancerPercy Lee, Jose G Bazan, Philip W Lavori, et al.
Cancer|January 2, 2009
Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreasDaniel T Chang, Devin Schellenberg, John Shen, et al.
The Lancet. Oncology|February 25, 2014
Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre studyChristopher Klenk, Rakhee Gawande, Lebriz Uslu, et al.
Pageof 10